Superinfections in COVID-19 patients receiving extracorporeal membrane oxygenation support.
Harald V AndersenVibeke R L JørgensenMorten SteensenFinn M PedersenMarie HellebergPublished in: Acta anaesthesiologica Scandinavica (2023)
Bacteremia and VAP are common but does not seem to affect mortality, whereas pulmonary aspergillosis and CMV are associated with poor prognosis among COVID-19 patients treated with VV-ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- poor prognosis
- coronavirus disease
- acute respiratory distress syndrome
- sars cov
- long non coding rna
- respiratory failure
- pulmonary hypertension
- respiratory syndrome coronavirus
- cardiovascular events
- risk factors
- type diabetes
- coronary artery disease
- cardiovascular disease
- multidrug resistant